Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CHOLESTEROL LEVELS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1008 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Thompson, PL
      Clinical relevance of statins: instituting treatment early in acute coronary syndrome patients

      ATHEROSCLEROSIS SUPPLEMENTS
    2. Tonkin, AM
      Clinical relevance of statins: their role in secondary prevention

      ATHEROSCLEROSIS SUPPLEMENTS
    3. Braunwald, E
      Changing the practice of cardiovascular medicine

      ATHEROSCLEROSIS SUPPLEMENTS
    4. Kobashigawa, JA
      Statins as immunosuppressive agents - Statins as a newly recognized type of immunomodulator

      LIVER TRANSPLANTATION
    5. Murphy, M; Shepherd, J
      Healthy ageing: Statin therapy opportunities - The 72nd European Atherosclerosis Society Congress - Foreword

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    6. Gaw, A
      Healthy ageing: addressing acute coronary syndrome?

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    7. Leitersdorf, E
      Cholesterol absorption inhibition: filling an unmet need in lipid-loweringmanagement

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    8. Aikawa, M; Libby, P
      Vascular inflammation and activation: new targets for lipid lowering

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    9. Game, FL; Bartlett, WA; Bayly, GR; Jones, AF
      Comparative accuracy of cardiovascular risk prediction methods in patientswith diabetes mellitus

      DIABETES OBESITY & METABOLISM
    10. Burnett, TR; Watts, GF
      Therapeutic considerations for postprandial dyslipidaemia

      DIABETES OBESITY & METABOLISM
    11. Cockcroft, JR; Wilkinson, IB; Yki-Jarvinen, H
      Multiple risk factor intervention in type 2 diabetes: an opportunity not to be missed

      DIABETES OBESITY & METABOLISM
    12. Bandyopadhyay, S; Bayer, AJ; O'Mahony, MS
      Age and gender bias in statin trials

      QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    13. Sharma, JC
      Non-neurological variables and mortality of acute stroke

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    14. Jackson, G
      Statins in acute coronary syndromes: from bench to bedside

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    15. den Hartog, FR; van Kalmthout, PM; van Loenhout, TT; Schaafsma, HJ; Rila, H; Verheugt, FWA
      Pravastatin in acute ischaemic syndromes: Results of a randomised placebo-controlled trial

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    16. Haq, IU; Ramsay, LE; Wallis, EJ; Isles, CG; Ritchie, LD; Jackson, PR
      Population implications of lipid lowering for prevention of coronary heartdisease: data from the 1995 Scottish Health Survey

      HEART
    17. Doggrell, SA
      Statins in the 21st century: end of the simple story?

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    18. Sheehy, N; Vaughan, CJ; Delanty, N
      Statins and neuroprotection

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    19. de Freitas, GR; Bogousslavsky, J
      Primary stroke prevention

      EUROPEAN JOURNAL OF NEUROLOGY
    20. Chaiyakunapruk, N; Boudreau, D; Ramsey, SD
      Pharmaco-economic impact of HMG-CoA reductase inhibitors in type 2 diabetes

      JOURNAL OF CARDIOVASCULAR RISK
    21. Holdaas, H; Fellstrom, B; Holme, I; Nyberg, G; Fauchald, P; Jardine, A; Gronhagen-Riska, C; Madser, S; Neumayer, HH; Cole, E; Maes, B; Weinreich, T; Olsson, AG; Pedersen, TR; Benghozi, R; Hartmann, A
      Effects of fluvastatin on cardiac events in renal transplant patients: ALERT (Assessment of Lescol (R) in Renal Transplantation) study design and baseline data

      JOURNAL OF CARDIOVASCULAR RISK
    22. Mas, R; Castano, G; Fernandez, L; Illnait, J; Fernandez, J; Alvarez, E
      Effects of policosanol on lipid profile and cardiac events in older hypercholesterolaemic patients with coronary disease

      CLINICAL DRUG INVESTIGATION
    23. Fernandez, JC; Mas, R; Catano, G; Menendez, R; Amor, AM; Gonzalez, RM; Alvarez, E
      Comparison of the efficacy, safety and tolerability of policosanol versus fluvastatin in elderly hypercholesterolaemic women

      CLINICAL DRUG INVESTIGATION
    24. Vaughan, CJ; Delanty, N; Basson, CT
      Do statins afford neuroprotection in patients with cerebral ischaemia and stroke?

      CNS DRUGS
    25. Franzosi, MG; Brunetti, M; Marchioli, R; Marfisi, RM; Tognoni, G; Valagussa, F
      Cost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction - Results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial

      PHARMACOECONOMICS
    26. McKenney, JM
      Lipid management: Tools for getting to the goal

      AMERICAN JOURNAL OF MANAGED CARE
    27. Mason, CM
      Identifying all suspects: Case studies

      AMERICAN JOURNAL OF MANAGED CARE
    28. Vogel, R; Schaefer, E
      Should all patients with cardiovascular disease receive statin therapy?

      AMERICAN JOURNAL OF MANAGED CARE
    29. Pedersen, T; Gaw, A
      Statins - Similarities and differences

      AMERICAN JOURNAL OF MANAGED CARE
    30. Rossi, A; Baldo-Enzi, G; Ganzaroli, C; Coscetti, G; Calabro, A; Baiocchi, MR; Maiolino, G; Pessina, AC; Rossi, GP
      Relationship of early carotid artery disease with lipoprotein (a), apolipoprotein B, and fibrinogen in asymptomatic essential hypertensive patients and normotensive subjects

      JOURNAL OF INVESTIGATIVE MEDICINE
    31. Eckel, RH
      Perspectives on vascular biology and diabetes

      JOURNAL OF INVESTIGATIVE MEDICINE
    32. Zambon, A; Brown, BG; Deeb, SS; Brunzell, JD
      Hepatic lipase as a focal point for the development and treatment of coronary artery disease

      JOURNAL OF INVESTIGATIVE MEDICINE
    33. Diomede, L; Albani, D; Sottocorno, M; Donati, MB; Bianchi, M; Fruscella, P; Salmona, M
      In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    34. Takemoto, M; Liao, JK
      Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    35. Cheng, JWM
      Recognition, pathophysiology, and management of acute myocardial infarction

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    36. O'Donnell, DC; Brown, CM; Piziak, VK
      Alternative therapy use and adherence to antihyperlipidemic drugs in a lipid clinic

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    37. Bismuth, J; Klitfod, L; Sillesen, H
      The lack of cardiovascular risk factor management in patients with critical limb ischaemia

      EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
    38. Archer, DF
      Progestogen effects on coronary arteries: the need for definitive clinicaltrials

      MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
    39. Buchgraber, M; Ulberth, F
      Determination of trans octadecenoic acids by silver-ion chromatography-gasliquid chromatography: An intercomparison of methods

      JOURNAL OF AOAC INTERNATIONAL
    40. Omar, MA; Wilson, JP; Cox, TS
      Rhabdomyolysis and HMG-CoA reductase inhibitors

      ANNALS OF PHARMACOTHERAPY
    41. Aldridge, MA; Ito, MK
      Colesevelam hydrochloride: A novel bile acid-binding resin

      ANNALS OF PHARMACOTHERAPY
    42. Marcus, A
      Current lipid-lowering strategies for the treatment of diabetic dyslipidemia: An integrated approach to therapy

      ENDOCRINOLOGIST
    43. Zlaket-Matta, G; Vela, BS; Brinton, EA
      The clinical relevance and management of high-density lipoprotein deficiency

      ENDOCRINOLOGIST
    44. Heath, KE; Humphries, SE; Middleton-Price, H; Boxer, M
      A molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH) in the United Kingdom

      EUROPEAN JOURNAL OF HUMAN GENETICS
    45. Christenson, JT
      Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization

      CARDIOVASCULAR SURGERY
    46. Steiner, G
      The use of fibrates and of statins in preventing atherosclerosis in diabetes

      CURRENT OPINION IN LIPIDOLOGY
    47. Gotto, AM; Farmer, JA
      Pleiotropic effects of statins: do they matter?

      CURRENT OPINION IN LIPIDOLOGY
    48. Reardon, CA; Getz, GS
      Mouse models of atherosclerosis

      CURRENT OPINION IN LIPIDOLOGY
    49. Hornig, B; Drexler, H
      Reversal of endothelial dysfunction in humans

      CORONARY ARTERY DISEASE
    50. Halcox, JPJ; Quyyumi, AA
      Coronary vascular endothelial function and myocardial ischemia: why shouldwe worry about endothelial dysfunction?

      CORONARY ARTERY DISEASE
    51. Laakso, M
      Cardiovascular disease in type 2 diabetes: challenge for treatment and prevention

      JOURNAL OF INTERNAL MEDICINE
    52. Leite, MCC; Nicolosi, A; Cristina, S; Hauser, WA; Nappi, G
      Nutrition and cognitive deficit in the elderly: a population study

      EUROPEAN JOURNAL OF CLINICAL NUTRITION
    53. Thomas, HP
      Classical cardiovascular risk factors: Prognostic value and treatment in elderly patients

      ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE
    54. Roesen, P; Ferber, P; Tschoepe, D
      Macrovascular disease in diabetes: current status

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    55. Boger, RH
      Drug interactions of them statins and consequences for drug selection

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    56. Bernini, F; Poli, A; Paoletti, R
      Safety of HMG-CoA reductase inhibitors: Focus on atorvastatin

      CARDIOVASCULAR DRUGS AND THERAPY
    57. Ohtani, M; Maruyama, K; Sugita, M; Kobayashi, K
      Amino acid supplementation affects hematological and biochemical parameters in elite rugby players

      BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
    58. Kaku, S; Yunoki, S; Ohkura, K; Sugano, M; Nonaka, M; Tachibana, H; Yamada, K
      Interactions of dietary fats and proteins on fatty acid composition of immune cells and LTB4 production by peritoneal exudate cells of rats

      BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
    59. Abbott, RD; Rodriguez, BL; Petrovitch, H; Yano, K; Schatz, IJ; Popper, JS; Masaki, KH; Ross, GW; Curb, JD
      Ankle-brachial blood pressure in elderly men and the risk of stroke: The Honolulu Heart Program

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    60. Garber, AJ; Karlsson, FO
      Treatment of dyslipidemia in diabetes

      ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
    61. Moussavi, RM; Ribas-Cardus, F; Rintala, DH; Rodriguez, GP
      Dietary and serum lipids in individuals with spinal cord injury living in the community

      JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT
    62. Game, FL; Jones, AF
      Coronary heart disease risk assessment in diabetes mellitus - a comparisonof PROCAM and Framingham risk assessment functions

      DIABETIC MEDICINE
    63. Raymond, LW; Tremarco, WE; Gerhard, H
      Asystole after Rinne testing: Beware the easy fainter

      AMERICAN JOURNAL OF EMERGENCY MEDICINE
    64. Walter, DH; Fichtlscherer, S; Britten, MB; Rosin, P; Auch-Schwelk, W; Schachinger, V; Zeiher, AM
      Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    65. Goldman, L; Phillips, KA; Coxson, P; Goldman, PA; Williams, L; Hunink, M; Weinstein, MC
      The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence mortality and cost

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    66. McPhail, IR; Spittell, PC; Weston, SA; Bailey, KR
      Intermittent claudication: An objective office-based assessment

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    67. Sevincok, L; Buyukozturk, A; Dereboy, F
      Serum lipid concentrations in patients with comorbid generalized anxiety disorder and major depressive disorder

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    68. Borba, EF; Bonfa, E
      Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy

      JOURNAL OF RHEUMATOLOGY
    69. Scripture, CD; Pieper, JA
      Clinical pharmacokinetics of fluvastatin

      CLINICAL PHARMACOKINETICS
    70. Jackson, PR; Wallis, EJ; Haq, IU; Ramsay, LE
      Statins for primary prevention: at what coronary risk is safety assured?

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    71. de Velasco, JA; Llargues, E; Fito, R; Sala, J; del Rio, A; de los Arcos, E; Llamas, A
      Risk factor prevalence and drug treatment in coronary patients hospital discharge. Results of a multicenter registry (3C programme)

      REVISTA ESPANOLA DE CARDIOLOGIA
    72. Martinez-Gonzalez, J; Llorente-Cortes, V; Badimon, L
      Cellular and molecular biology of atherosclerotic lesions

      REVISTA ESPANOLA DE CARDIOLOGIA
    73. Elisaf, M
      The treatment of coronary heart disease: An update - Part 1: An overview of the risk factors for cardiovascular disease

      CURRENT MEDICAL RESEARCH AND OPINION
    74. Niemeijer-Kanters, SDJM; Banga, JD; Erkelens, DW
      Lipid-lowering therapy in diabetes mellitus

      NETHERLANDS JOURNAL OF MEDICINE
    75. Taylor, AJ; Grace, K; Swiecki, J; Hyatt, R; Gibbs, H; Sheikh, M; O'Malley, PG; Lowenthal, SP; West, M; Spain, J; Maneval, K; Jones, DL
      Lipid-lowering efficacy, safety, and costs of a large-scale therapeutic statin formulary conversion program

      PHARMACOTHERAPY
    76. Straka, RJ; Taheri, R; Cooper, SL; Tan, AWH; Smith, JC
      Assessment of hypercholesterolemia control in a managed care organization

      PHARMACOTHERAPY
    77. Tsuyuki, RT; Bungard, TJ
      Poor adherence with hypolipidemic drugs: A lost opportunity

      PHARMACOTHERAPY
    78. Hilleman, DE; Wurdeman, RL; Lenz, TL
      Therapeutic change of HMG-CoA reductase inhibitors in patients with coronary artery disease

      PHARMACOTHERAPY
    79. Tsuyuki, RT; Bungard, T
      Do hypolipidemic drugs lower medical expenses? Authors' reply

      PHARMACOTHERAPY
    80. Jafari, M; Masih, M; Emerson, JF
      The value of pharmacist involvement in a point-of-care service, walk-in lipid screening program

      PHARMACOTHERAPY
    81. Hilleman, DE; Monaghan, MS; Ashby, CL; Mashni, JE; Woolley, K; Amato, CM
      Physician-prompting statin therapy intervention improves outcomes in patients with coronary heart disease

      PHARMACOTHERAPY
    82. Tonelli, M; Bohm, C; Pandeya, S; Gill, J; Levin, A; Kiberd, BA
      Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency

      AMERICAN JOURNAL OF KIDNEY DISEASES
    83. Kratky, D; Strauss, JG; Zechner, R
      Tissue-specific activity of lipoprotein lipase in skeletal muscle regulates the expression of uncoupling protein 3 in transgenic mouse models

      BIOCHEMICAL JOURNAL
    84. Sever, PS; Dahlof, B; Poulter, NR; Wedel, H; Beevers, G; Caulfield, M; Collins, R; Kjeldsen, SE; McInnes, GT; Mehlsen, J; Nieminen, M; O'Brien, E; Ostergren, J
      Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian cardiac outcomes trial

      JOURNAL OF HYPERTENSION
    85. Damasceno, NRT; Gidlund, MA; Goto, H; Dias, CTS; Okawabata, FS; Abdalla, DSP
      Casein and soy protein isolate in experimental atherosclerosis: Influence on hyperlipidemia and lipoprotein oxidation

      ANNALS OF NUTRITION AND METABOLISM
    86. Miller, CA
      Update on statins and other lipid-lowering drugs

      GERIATRIC NURSING
    87. Arad, Y; Newstein, D; Roth, M; Guerci, AD
      Rationale and design of the St. Francis Heart Study: A randomized clinicaltrial of atorvastatin plus antioxidants in asymptomatic persons with elevated coronary calcification

      CONTROLLED CLINICAL TRIALS
    88. Oja, P
      Dose response between total volume of physical activity and health and fitness

      MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
    89. van Hout, BA; Simoons, ML
      Cost-effectiveness of HMG coenzyme reductase inhibitors - Whom to treat?

      EUROPEAN HEART JOURNAL
    90. Real, JT; Chaves, FJ; Martinez-Uso, I; Garcia-Garcia, AB; Ascaso, JF; Carmena, R
      Importance of HDL cholesterol levels and the total/HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia

      EUROPEAN HEART JOURNAL
    91. Ridker, PM
      Should statin therapy be considered for patients with elevated C-reactive protein? The need for a definitive clinical trial

      EUROPEAN HEART JOURNAL
    92. Musial, J; Undas, A; Gajewski, P; Jankowski, M; Sydor, W; Szczeklik, A
      Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    93. Isaacsohn, J; Insull, W; Stein, E; Kwiterovich, P; Ma, P; Brazg, R; Dujovne, CA; Shan, M; Shugrue-Crowley, E; Ripa, S; Tota, R
      Long-term efficacy and safety of cerivastatin 0.8 mg in patients with primary hypercholesterolemia

      CLINICAL CARDIOLOGY
    94. Waters, DD
      What do the statin trials tell us?

      CLINICAL CARDIOLOGY
    95. Gotto, AM
      How do we achieve optimal cardiovascular risk reduction?

      CLINICAL CARDIOLOGY
    96. Hennekens, CH
      Current perspectives on lipid lowering with statins to decrease risk of cardiovascular disease

      CLINICAL CARDIOLOGY
    97. Auer, J; Berent, R; Eber, B
      Lessons learned from statin trials

      CLINICAL CARDIOLOGY
    98. Choe, SC; Kim, HS; Jeong, TS; Bok, SH; Park, YB
      Naringin has an antiatherogenic effect with the inhibition of intercellular adhesion molecule-1 in hypercholesterolemic rabbits

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    99. Unlu, S; Clunn, G; Schachter, M; Demoliou-Mason, C; Hughes, AD
      Action of an HMG CoA reductase inhibitor, lovastatin, on apoptosis of untransformed and ts-SV40 transformed human smooth muscle cells derived from saphenous vein

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    100. Sabia, H; Prasad, P; Smith, HT; Stoltz, RR; Rothenberg, P
      Safety, tolerability, and pharmacokinetics of an extended-release formulation of fluvastatin administered once daily to patients with primary hypercholesterolemia

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/05/20 alle ore 11:45:22